These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35585008)

  • 21. The dual function of KSR1: a pseudokinase and beyond.
    Zhang H; Koo CY; Stebbing J; Giamas G
    Biochem Soc Trans; 2013 Aug; 41(4):1078-82. PubMed ID: 23863182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein engineering strategies to stimulate the functions of bacterial pseudokinases.
    Yang X; Kowallis KA; Childers WS
    Methods Enzymol; 2022; 667():275-302. PubMed ID: 35525544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the evolutionary conservation of the sole PIKK pseudokinase Tra1/TRRAP.
    Elías-Villalobos A; Fort P; Helmlinger D
    Biochem Soc Trans; 2019 Dec; 47(6):1597-1608. PubMed ID: 31769470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Ligand Binding to Pseudokinases Using a Thermal Shift Assay.
    Lucet IS; Murphy JM
    Methods Mol Biol; 2017; 1636():91-104. PubMed ID: 28730475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divalent metal ions control activity and inhibition of protein kinases.
    Knape MJ; Ballez M; Burghardt NC; Zimmermann B; Bertinetti D; Kornev AP; Herberg FW
    Metallomics; 2017 Nov; 9(11):1576-1584. PubMed ID: 29043344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudokinase drug intervention: a potentially poisoned chalice.
    Claus J; Cameron AJ; Parker PJ
    Biochem Soc Trans; 2013 Aug; 41(4):1083-8. PubMed ID: 23863183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. There's more to death than life: Noncatalytic functions in kinase and pseudokinase signaling.
    Mace PD; Murphy JM
    J Biol Chem; 2021; 296():100705. PubMed ID: 33895136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enabling pseudokinases as potential drug targets.
    Preuss F; Chatterjee D; Dederer V; Knapp S; Mathea S
    Methods Enzymol; 2022; 667():663-683. PubMed ID: 35525558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric protein kinase regulation by pseudokinases: insights from STRAD.
    Rajakulendran T; Sicheri F
    Sci Signal; 2010 Mar; 3(111):pe8. PubMed ID: 20197543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redefining pseudokinases: A look at the untapped enzymatic potential of pseudokinases.
    Pon A; Osinski A; Sreelatha A
    IUBMB Life; 2023 Apr; 75(4):370-376. PubMed ID: 36602414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization.
    Ha BH; Boggon TJ
    J Biol Chem; 2018 Feb; 293(5):1642-1650. PubMed ID: 29212708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence without catalysis: how can a pseudokinase affect host cell signaling?
    Reese ML; Boyle JP
    Trends Parasitol; 2012 Feb; 28(2):53-7. PubMed ID: 22257555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudokinases from a structural perspective.
    Taylor SS; Shaw A; Hu J; Meharena HS; Kornev A
    Biochem Soc Trans; 2013 Aug; 41(4):981-6. PubMed ID: 23863167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolutionary and cellular analysis of the 'dark' pseudokinase PSKH2.
    Byrne DP; Shrestha S; Daly LA; Marensi V; Ramakrishnan K; Eyers CE; Kannan N; Eyers PA
    Biochem J; 2023 Jan; 480(2):141-160. PubMed ID: 36520605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of pseudokinases in cancer.
    Zhang H; Photiou A; Grothey A; Stebbing J; Giamas G
    Cell Signal; 2012 Jun; 24(6):1173-84. PubMed ID: 22330072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase.
    Kerr JS; Wilson CH
    Biochem Soc Trans; 2013 Aug; 41(4):1055-60. PubMed ID: 23863178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification, crystallization and drug screening of the IRAK pseudokinases.
    Lange SM; Kulathu Y
    Methods Enzymol; 2022; 667():101-121. PubMed ID: 35525539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the HER3 pseudokinase domain with small molecule inhibitors.
    Colomba A; Claus J; Gao F; George R; Fornili A; Cameron AJM
    Methods Enzymol; 2022; 667():455-505. PubMed ID: 35525551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into the evolution of divergent nucleotide-binding mechanisms among pseudokinases revealed by crystal structures of human and mouse MLKL.
    Murphy JM; Lucet IS; Hildebrand JM; Tanzer MC; Young SN; Sharma P; Lessene G; Alexander WS; Babon JJ; Silke J; Czabotar PE
    Biochem J; 2014 Feb; 457(3):369-77. PubMed ID: 24219132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties.
    Murphy JM; Zhang Q; Young SN; Reese ML; Bailey FP; Eyers PA; Ungureanu D; Hammaren H; Silvennoinen O; Varghese LN; Chen K; Tripaydonis A; Jura N; Fukuda K; Qin J; Nimchuk Z; Mudgett MB; Elowe S; Gee CL; Liu L; Daly RJ; Manning G; Babon JJ; Lucet IS
    Biochem J; 2014 Jan; 457(2):323-34. PubMed ID: 24107129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.